Earnings estimate

Search documents
Gear Up for Freeport-McMoRan (FCX) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-18 14:15
Wall Street analysts expect Freeport-McMoRan (FCX) to post quarterly earnings of $0.46 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $7.12 billion, up 7.5% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 11% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's earning ...
Moody's (MCO) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-07-18 14:15
Wall Street analysts forecast that Moody's (MCO) will report quarterly earnings of $3.42 per share in its upcoming release, pointing to a year-over-year increase of 4.3%. It is anticipated that revenues will amount to $1.85 billion, exhibiting an increase of 1.8% compared to the year-ago quarter.Over the last 30 days, there has been an upward revision of 1.5% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their ...
Curious about Tesla (TSLA) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-07-18 14:15
Core Viewpoint - Tesla is expected to report a decline in quarterly earnings and revenues, with earnings per share projected at $0.40, a decrease of 23.1% year-over-year, and revenues forecasted at $22.48 billion, down 11.9% from the previous year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised downward by 3.9%, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts forecast 'Revenues- Automotive sales' to be $16.43 billion, reflecting a decrease of 11.3% year-over-year [5]. - 'Revenues- Energy generation and storage' is expected to reach $3.38 billion, indicating an increase of 12.1% from the previous year [5]. - 'Revenues- Services and other' are projected at $2.92 billion, showing a year-over-year increase of 11.9% [5]. Geographic Revenue Estimates - 'Geographic Revenues- United States' is estimated to be $11.93 billion, down 10% from the year-ago quarter [6]. - 'Geographic Revenues- Other International' is projected at $7.40 billion, a decrease of 2.7% year-over-year [7]. - 'Geographic Revenues- China' is expected to reach $5.09 billion, reflecting a growth of 9.7% from the prior year [7]. Vehicle Deliveries - Total vehicle deliveries are estimated at 383,180, down from 443,956 in the same quarter last year [7]. - 'Model 3/Y deliveries' are projected at 370,703, compared to 422,405 in the same quarter of the previous year [8]. - 'Other models deliveries' are expected to be 15,964, down from 21,551 in the same quarter last year [8]. Storage Deployment - Analysts project 'Storage deployed' to reach 10,655 megawatt hours, an increase from 9,400 megawatt hours reported in the same quarter last year [9]. Stock Performance - Tesla shares have returned -0.8% over the past month, contrasting with the Zacks S&P 500 composite's +5.4% change, indicating expected underperformance in the near future [9].
Is Most-Watched Stock Alphabet Inc. (GOOGL) Worth Betting on Now?
ZACKS· 2025-07-18 14:01
Alphabet (GOOGL) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this internet search leader have returned +5.9%, compared to the Zacks S&P 500 composite's +5.4% change. During this period, the Zacks Internet - Services industry, which Alphabet falls in, has gained 4.9%. The key question now is: What could be the stock's future direction?While media relea ...
Townsquare (TSQ) Surges 6.9%: Is This an Indication of Further Gains?
ZACKS· 2025-07-18 13:46
Townsquare Media (TSQ) shares ended the last trading session 6.9% higher at $9.05. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 19.5% gain over the past four weeks.Townsquare is benefiting from the expansion of its programmatic digital advertising services, growth in its subscription-based marketing platform, and partnerships with local media companies across underserved markets.This operator of radio stations i ...
Amazon: Strong Industry, Solid Earnings Estimate Revisions
ZACKS· 2025-07-18 13:31
One stock that might be an intriguing choice for investors right now is Amazon.com, Inc. (AMZN) . This is because this security in the Internet - Commerce space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Inter ...
Schlumberger (SLB) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-18 13:00
Schlumberger (SLB) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.37%. A quarter ago, it was expected that this world's largest oilfield services company would post earnings of $0.74 per share when it actually produced earnings of $0.72, delivering a surprise of -2.7%.Over the las ...
Comerica Incorporated (CMA) Q2 Earnings and Revenues Beat Estimates
ZACKS· 2025-07-18 12:31
Core Viewpoint - Comerica Incorporated (CMA) reported quarterly earnings of $1.42 per share, exceeding the Zacks Consensus Estimate of $1.23 per share, but down from $1.53 per share a year ago, indicating an earnings surprise of +15.45% [1][2] Financial Performance - The company posted revenues of $849 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.51% and up from $824 million year-over-year [2] - Over the last four quarters, Comerica has exceeded consensus EPS estimates three times and has topped consensus revenue estimates three times as well [2] Stock Performance and Outlook - Comerica shares have increased by approximately 0.9% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The company's current consensus EPS estimate for the upcoming quarter is $1.32 on revenues of $856.2 million, and for the current fiscal year, it is $5.08 on revenues of $3.39 billion [7] Industry Context - The Zacks Industry Rank for Banks - Major Regional is currently in the top 7% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment [5]
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
ZACKS· 2025-07-18 12:26
Company Overview - Legend Biotech Corporation's shares increased by 6% to close at $42.13, with a notable trading volume compared to normal sessions, and a total gain of 13.9% over the past four weeks [1][2] Product Performance - The rise in stock price is attributed to investor optimism regarding the strong sales of Carvykti, a therapy for relapsed or refractory multiple myeloma, developed in partnership with Johnson & Johnson [2] Financial Expectations - The company is projected to report a quarterly loss of $0.18 per share, reflecting a year-over-year decline of 260%, while revenues are expected to reach $233.67 million, marking a 25.3% increase from the previous year [3] - The consensus EPS estimate for the upcoming quarter has been revised 4.1% higher in the last 30 days, indicating a potential for price appreciation [4] Industry Context - Legend Biotech is categorized within the Zacks Medical - Biomedical and Genetics industry, where Vanda Pharmaceuticals, another company in the same sector, has also shown a 1% increase in its stock price recently [4] - Vanda's consensus EPS estimate remains unchanged at -$0.34, representing a 325% decline from the previous year [5]
Strength Seen in Belden (BDC): Can Its 3.6% Jump Turn into More Strength?
ZACKS· 2025-07-18 12:15
Company Overview - Belden's shares increased by 3.6% to close at $130.81, with notable trading volume compared to typical sessions, and a total gain of 15.4% over the past four weeks [1] - In Q1 2025, Belden's revenues rose by 16.6% year-over-year to $625 million, surpassing the Zacks Consensus Estimate of $613 million, while adjusted earnings per share (EPS) were $1.60, exceeding the estimate of $1.48, marking a 29% year-over-year increase [2] - The upcoming quarterly earnings report is expected to show EPS of $1.72, reflecting a year-over-year increase of 13.9%, with revenues projected at $653 million, an 8.1% increase from the previous year [3] Earnings Estimates and Market Position - The consensus EPS estimate for Belden has remained unchanged over the last 30 days, indicating that stock price movements may not continue without trends in earnings estimate revisions [4] - Belden holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook, while another company in the same industry, Atkore Inc., also holds a Zacks Rank of 3 and has seen a 3.4% increase in its stock price [4][5]